ThinkstockPhotos-dv2062026 smile lowsatp

Tumor Profiling

How is your patient’s tumor profiled?

Tumor tissue is obtained during biopsy or surgery and the oncologist will send that tissue to our CLIA certified laboratory using our special collection kit. Two samples of the tumor tissue are obtained, fixed and live. The fixed tumor tissue is used for a panel of biomarker tests (e.g. BRAF, HER2 etc) using genomics. The live tumor tissue is grown in the lab and used to test the drug response of the tumor to a panel  standard-of-care (SOC) drugs. When testing is complete a report is provided back to the clinician with recommended SOC therapies based on the drug response and genomic profiles.

Why individualize your patient’s therapy?
Clinical validation of in vitro cell-based profiling
  • 14 mo improvement in overall survival

  • 50% percentage improvement in progressive free survival

  • 2.5x longer life-span for patients treated with ChemoFX specified agent

  • 51% potential for savings for ovarian cancer treatment

Informative, clear Final Report
Final Report Page 2.PNG
Final Report page 3.PNG
The Precision Oncology Insights process

Data from the patient

Data from the patient’s tumor (functional tumor testing)

Compare to TumorSpace knowledgebase of genomic and drug response profiles

Information “roadmap” to empower the oncologist to individualize therapy

Oncologist determines course of treatment for the patient